Skip to content

Dagmara Mirowska-Guzeł

2 papers in the library · 11 citations · publishing 2024-2026

Papers

Sort Most recent Most cited

Psilocibin: Current Evidence, Safety Signals, and Challenges in Assessing Potential Multi-Organ Effects

Biomedicines July 6, 2026 Kasper Buczma, Katarzyna Kamińska, Kaja Kasarełło et al.

Background/Objectives: Psilocibin (PSY), a serotonergic hallucinogen, has attracted increasing scientific interest due to its therapeutic potential, particularly in treatment-resistant depression. In parallel with its growing clinical and research relevance, important questions have emerged regarding its safety profile, including potential effects on the liver, kidneys, cardiovascular system,...

DOI: 10.3390/biomedicines14071516 (opens in new tab) Serotonergic Narrative review Context archaeology Adverse effect +9

Psilocybin in pharmacotherapy of obsessive-compulsive disorder

Pharmacological Reports August 1, 2024 Maja Owe-Larsson, Katarzyna Kamińska, Barbara Buchalska et al. 11 citations

Abstract Obsessive-compulsive disorder (OCD) is a chronic mental disease that affects approximately 2% of the population. Obsessions and compulsions are troublesome for patients and may disturb their everyday activities. The pathogenesis of this disease is still not fully elucidated, but dysfunctions of serotonin-, dopamine- and glutamate-mediated neurotransmission together with early...